Montreal, Canada

Craig Hasilo

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Craig Hasilo: Innovator in Cellular Transplantation

Introduction

Craig Hasilo is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of cellular transplantation, holding a total of 4 patents. His innovative work focuses on developing methods and devices that enhance the effectiveness of cell transplantation in host bodies.

Latest Patents

Hasilo's latest patents revolve around advanced devices and methods for transplanting cells. One of his key inventions includes a device that features a porous scaffold designed to facilitate the ingrowth of vascular and connective tissues. This device incorporates a plug system that is strategically placed within the scaffold, along with a seal that encloses a proximal opening. Additionally, the device may include a cell delivery mechanism for introducing cells into the scaffold. The transplantation method he developed involves a two-step process where the device is first incubated in the host body to create a vascularized collagen matrix. Following this, the plug is retracted, allowing for the delivery of cells into the newly formed vascularized space.

Career Highlights

Craig Hasilo is currently associated with Sernova Corporation, where he continues to push the boundaries of innovation in cellular transplantation. His work is pivotal in advancing medical technologies that can improve patient outcomes.

Collaborations

Hasilo collaborates with talented individuals such as Justin Leushner and Daniel Nicholas Haworth, contributing to a dynamic team focused on groundbreaking research and development.

Conclusion

Craig Hasilo's contributions to cellular transplantation exemplify the spirit of innovation in the medical field. His patents and ongoing work at Sernova Corporation are set to make a lasting impact on how cell transplantation is approached in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…